Cardura Xl Extended Release Tablets 4 mg Bottle Label (Image 01)
Cardura Tablet, Film Coated, Extended Release
Product Images NDC 58151-078
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Cardura (NDC 58151-078). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Viatris Specialty Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Cardura Xl Extended Release Tablets 8 mg Bottle Label (Image 02)
Doxazosin Mesylate Structural Formula (Image 03)
Figure 1: Mean (+sd) Plasma Concentration Of Doxazosin Following Single Oral Doses Of 8 mg Cardura Xl (fed And Fasted) (Image 04)
Figure 2: Mean Total Ipss (± Se) By Week In Study 1 (Image 05)
Figure 3: Mean Maximum Urinary Flow Rate (ml/sec) (± Se) By Week In Study 1 (Image 06)
Mean Max Urinary Flow Rate (mL/sec) is a measure of the maximum rate at which urine flows during urination. It is represented in mL/sec. The given text provides some numerical values, including 15, 13, 2, 1, 10, 5, 7, 8, 9, which appear to be related to the measurement. Additionally, the text mentions "Weeks of Treatment," which suggests that the mentioned values might be associated with a treatment period. However, the has failed to accurately decipher the remaining text, resulting in "Plsosbo." Hence, the description is inconclusive.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
